William E. Lafferty, MD

Articles by William E. Lafferty, MD

Complementary and Alternative Medicine Provider Use and Expenditures by Cancer Treatment Phase

ByWilliam E. Lafferty, MD,Patrick T. Tyree, AA,Sean M. Devlin, MA,M. Robyn Andersen, PhD, MPH,Paula K. Diehr, PhD

May 15th 2008

More than 26% of cancer patients see CAM providers, primarily for musculoskeletal problems; use does not vary by treatment phase, and associated expenditures are low.

Insurance Coverage and Subsequent Utilization of Complementary and Alternative Medicine Providers

ByWilliam E. Lafferty, MD,Patrick T. Tyree, AA,Allen S. Bellas, PhD,Carolyn A. Watts, PhD,Bonnie K. Lind, PhD,Karen J. Sherman, PhD,Daniel C. Cherkin, PhD,David E. Grembowski, PhD

July 15th 2006

William E. Lafferty, MD

Articles by William E. Lafferty, MD

Complementary and Alternative Medicine Provider Use and Expenditures by Cancer Treatment Phase

Insurance Coverage and Subsequent Utilization of Complementary and Alternative Medicine Providers

Latest Updated Articles

Trending on AJMC

Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss

Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year

Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD

Nutrition in Pregnancy May Shape Metabolic Health After Delivery

Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD